One day nanobots will probably travel through our bloodstreams to keep us young and healthy. American author and futurist Ray Kurzweil writes in his book The Singularity Is Near: “When nanotechnology is mature, it’s going to solve the problems of biology by overcoming biological pathogens, removing toxins, correcting DNA errors, and reversing other sources of aging”. Needless to say that day is yet to come, but today we can already inject ourselves with millennial blood to stay young indefinitely, according to clinical startup Ambrosia.
The company is currently enrolling 600 people to undergo a clinical trial in which elderly volunteers pay a generous amount to receive 1.5 liters of millennial donorplasma in just two days. Their blood will be tested before and after the infusions for more than 100 biomarkers, which according to the company “represent a spectrum of physiologic pathways with evidence-based connections to aging”. The intended results will be shared on their federal website to track human trials. However, bioethicist Leigh Turner at the University of Minnesota, Twin Cities, says the study raises a growing number of scientifically dubious trials registered in ClinicalTrials.gov by private, for-profit stem cell clinics, and speaks of “undeserved legitimacy” when it comes to such databases.
Ironically, the research sounds like it needs some aging. According to Kurzweil, “within ten to twenty years, the biotechnology revolution will provide far more powerful means to stop and in many cases reverse each disease and aging process […] Each year, we’ll have more powerful techniques, and process will accelerate. Then nanotechnology will finish the job”.